ClinicalTrials.gov
public full text
Public Domain
A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)
To investigate the safety and efficacy of abatacept with steroid treatment in comparison to steroid treatment alone in up to a 28 week taper of steroid treatment to sustain remission of Giant Cell Arteritis in adults.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- TocilizuMab discontinuAtion in GIant Cell Arteritis#883768
- Assessment of Giant Cell Arteritis Medical Practices in France#847703
- Measurement of the impact of giant cell arteritis and treatment with glucocorticoids on health-related quality of life.#423160
- Giant Cell Arteritis - Ways to Precision Medicine#856892
- Development of a Target Product Profile for a Proteomic Blood Test to Aid the Diagnosis of Cranial Giant Cell Arteritis - <i>Study protocol</i>#1090075
Record · ID 992424
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive